The levels of ELAM-1 were highly elevated in patients with thrombosis (60 ± 5 ng/mL) compared to those without thrombosis (30 ± 1 ng/mL) and the controls (25 ± 5 ng/mL) (p < 0.0001). This evidence concerns the gene SELE and deep vein thrombosis.